Gut Microbiome Components Predict Response to Neoadjuvant Therapy in HER2-positive Breast Cancer Patients : A Prospective Study

NCT05444647 · clinicaltrials.gov ↗

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

PROCEDURE: stool and blood collection

Sponsor

The First Affiliated Hospital with Nanjing Medical University